TC
The Column Group
Venture CapitalActiveThe Column Group is a California-based venture capital firm dedicated to developing biotechnology companies.
75
Investments
7
Exits
$4B
AUM
9.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for The Column Group.
Investment Thesis & Strategy
The Column Group invests in various stages of biotechnology companies. They focus on developing companies in the biotechnology industry.
Investment Activity
Deals per year over the last 6 years
2
20163
20173
20181
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 75 companies
K
Kyverna Therapeutics
Biotech · Series A, 2021
V
Ventyx Biosciences
Biotech · Series A, 2021
R
Rgenta Therapeutics
Biotech · Series A, 2021
V
Verve Therapeutics
Biotech · Series A, 2019
C
Casma Therapeutics
Biotech · Series A, 2018
C
Carmot Therapeutics
Biotech · Series A, 2018
L
Lycia Therapeutics
Biotech · Series A, 2018
G
Gossamer Bio
Biotech · Series A, 2017
T
Turning Point Therapeutics
Biotech · Series A, 2017
B
Black Diamond Therapeutics
Biotech · Series A, 2017
A
Alector
Biotech · Series A, 2016
B
BridgeBio Pharma
Biotech · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
Collective HealthAcquisition2024—
Grand RoundsAcquisition2021$1.8B
Health CatalystIPO2019$1.1B
LivongoIPO2019$3.6B
Flatiron HealthAcquisition2018$1.9B
Castlight HealthIPO2014$3B
Veeva SystemsIPO2013$4B
Frequently Asked Questions
The Column Group focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals